Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04289350
Other study ID # fHRV_2
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 1, 2018
Est. completion date July 1, 2020

Study information

Verified date February 2020
Source University of Aarhus
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study evaluates the day-to-day variation in fetal heart rate variability based on non-invasive fetal-ECG (NI-FECG). Furthermore, the effect of fetal movements on fetal heart rate variability will be assessed.


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date July 1, 2020
Est. primary completion date July 1, 2020
Accepts healthy volunteers
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - Healthy singleton pregnant women with an expected healthy fetus Exclusion Criteria: - fetal malformations, multiple pregnancy, obstetric complications, maternal chronic disease and labor. Low birth weight or malformation diagnosed at birth.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
fetal heart rate variability
An observational study. No intervention

Locations

Country Name City State
Denmark Department of Obstetrics and Gynecology. Aarhus Unive Aarhus Aarhus N

Sponsors (7)

Lead Sponsor Collaborator
University of Aarhus Aarhus University Hospital, AP Moeller Foundation, Augustinus Fonden, Hartmann Fonden, Snedkermester Sophus Jacobsen and hustru Astrid Jacobsens Foundation, The Dagmar Marshall Foundation

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Root mean square of successive inter beat interval differences (RMSSD) Time domain analysis 1/8-2020
Primary Standard deviation of normal to normal inter beat interval (SDNN) Time domain analysis 1/8-2020
Primary High frequency power (HF-power) Spectral analysis 1/8-2020
Primary Low frequency power (LF-power) spectral analysis 1/8-2020
Primary Low frequency power/High frequency power (LF/HF) Spectral analysis 1/8-2020
See also
  Status Clinical Trial Phase
Recruiting NCT05899101 - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed NCT04502823 - Management of Fetal Growth Restriction at Term: Angiogenic Factors Versus Feto-placental Doppler N/A
Not yet recruiting NCT03625518 - Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes Early Phase 1
Completed NCT05176041 - SLE Therapy Changes in Pregnancy and Relation to Pregnancy Outcome
Completed NCT02379728 - Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth N/A
Completed NCT01695070 - Melatonin to Prevent Brain Injury in Unborn Growth Restricted Babies Phase 4
Completed NCT01352234 - Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia Phase 4
Recruiting NCT03662178 - Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
Recruiting NCT05023161 - Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction
Completed NCT02590536 - A Trial Evaluating the Role of Sildenafil in the Treatment of Fetal Growth Restriction Phase 3
Not yet recruiting NCT05029778 - Arginine + Citrulline as a Supplement for Weight Gain in Fetus With a Decrease in Their Growth Curve Phase 4
Recruiting NCT05576207 - BEP Supplementation Research in Bangladesh (JiVitA-BEP-IR) N/A
Active, not recruiting NCT05160649 - Effect of Covid 19 Infection on Fetomaternal Outcome
Completed NCT02280031 - Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial. Phase 2
Recruiting NCT04389099 - MRI Angiography of Physiological and Pathological Pregnancy Placentas Ex-vivo
Recruiting NCT06039319 - Acute Effects of Maternal Exercise and the Growth Restricted Pregnancy
Recruiting NCT05651347 - Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction Phase 3
Recruiting NCT02336243 - A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders Phase 3
Active, not recruiting NCT01594463 - Routine Ultrasound Screening in the Third Trimester N/A
Completed NCT00465634 - Doppler and Biological Second Trimester Placental Insufficiency Screening N/A